In 2020, the global Rosuvastatin Calcium market size was US$ 502 million and it is expected to reach US$ 665.1 million by the end of 2027, with a CAGR of 4.0% during 2022-2027.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
It is an approved API which can be used to reduce the risk of stroke or heart attack. Rosuvastatin calcium is a hygroscopic powder suitable for the manufacturing of capsules and tablets in which the appropriate excipients need to be added. Depending on formulation, the particle size of product is designed is a way that optimal dissolution can be obtained.
Rosuvastatin calcium is a member of the drug class of statins which is used in combination diet, exercise and weight-loss in order to treat high cholesterol and conditions related to it along with preventing cardiovascular disease. It operates by slowing the production of cholesterol in the body in order to decrease the amount of cholesterol which may build up on the walls of the arteries and block the blood flow to the brain, heart and other parts of the body.
Industry Updates:
Rosuvastatin Calcium Market is segmented based on the type, applications, companies and regions.
Market Volume (%) By Type, it is segmented into
Market Volume (%) By Applications it is segmented into
Europe remains the largest consumer of Rosuvastatin calcium with a share of 34% meanwhile China is the second producer with a market share of 28%. Key players in the market are, MSN laboratories, AstraZeneca and Changzhou pharmaceutical factory with a combined market share of 55%.
All these factors greatly affect the Rosuvastatin Calcium market growth. It further aims at providing complete overview on detailed assessment of significant features of different industries including sales value, sales volume, market revenue, and demand size, sales growth, pricing analysis and changing market growth factors in regions such as Follows,
The Rosuvastatin Calcium Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Rosuvastatin Calcium Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes
| Report Details |
Forecast Period 2022 to 2027 CAGR (Value and Volume) |
CAGR of 4.0% during the review period (2022 to 2027). |
Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022) |
|
Market Volume (%) By Type(Revenue, USD Million, 2017 - 2022) |
|
Quantitative units | Revenue in USD million/billion and CAGR from 2022 to 2027 |
By Companies | AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, HEC Pharm, Lunan Pharmaceutical, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Shandong Bechem Chemicals, CTX Life Sciences |
Regions Covered |
|
Countries Covered |
|
Base Year
|
2022 |
Historical Year
|
2017 to 2021 |
Forecast Year
|
2022 to 2027 |
Customization Available
|
Yes, the report can be customized as per your needs |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
What is the study period of this market?
The Rosuvastatin Calcium Market is studied from 2017 - 2027.
What is the growth rate of Rosuvastatin Calcium Market?
The Rosuvastatin Calcium Market is growing at a CAGR of 4.0% over the next 5 years.
Who are the key players in Rosuvastatin Calcium Market?
AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, HEC Pharm, Lunan Pharmaceutical, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Shandong Bechem Chemicals, CTX Life Sciences
What region does this Rosuvastatin Calcium Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Rosuvastatin Calcium Market?
Purity 98.0%, Purity 99.0%, Others
What are the major end-use applications of Rosuvastatin Calcium Market?
Tablet (including dispersible tablet and general tablet), Capsule, Others.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.